H. Gharib et El. Mazzaferri, THYROXINE SUPPRESSIVE THERAPY IN PATIENTS WITH NODULAR THYROID-DISEASE, Annals of internal medicine, 128(5), 1998, pp. 386-394
Purpose: To review evidence about thyroxine suppressive therapy in pat
ients with thyroid nodules, including the clinical importance and natu
ral history of nodules and the effects and potential side effects of t
hyroxine therapy. Data Sources: English-language articles published fr
om 1986 to December 1996 were identified through searches of the MEDLI
NE database, selected bibliographies, and personal files. Data Extract
ion: Randomized, controlled trials and nonrandomized trials of thyroxi
ne suppressive therapy for solitary and predominantly solid thyroid no
dules were reviewed. In most studies, nodule cytology was evaluated by
fine-needle aspiration biopsy. Therapy was considered suppressive if
suppression was documented by thyroid-stimulating hormone-releasing ho
rmone tests or sensitive thyroid-stimulating hormone assays. Response
was defined as a decrease of 50% or more in nodule size or volume; mos
t recent studies measured nodule size by ultrasonography. Data Synthes
is: The evidence suggests that thyroxine suppressive therapy fails to
shrink most nodules: Only 10% to 20% of nodules responded to this trea
tment. Fine-needle aspiration biopsy is more reliable in distinguishin
g benign from malignant nodules. Recent studies suggest that spontaneo
us decrease in size with complete disappearance of thyroid nodules is
not uncommon. No data show that thyroxine therapy arrests further grow
th in most existing nodules or prevents the emergence of new nodules.
Postoperative thyroxine therapy does not seem to prevent recurrence of
thyroid nodules except in patients with a history of radiation therap
y. Potential adverse effects of long-term suppressive therapy include
osteoporosis and heart disease. Conclusions: Patients with cytological
ly benign nodules are best followed without thyroxine treatment. Most
benign nodules remain stable in size and remain benign when monitored
for a long time. For nodules that increase in size, biopsy should be d
one again or surgery should be performed.